CytRx OverviewLatest common stock for CYTR: $500K.
Get informed when a big investor buys or sells
+ Follow
Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.
As of the most recent data (March 2025), CYTR shows a common stock of $500K. Scroll down for historical charts and peer comparison views.
Tracking CYTR's common stock over time shows whether CytRx is scaling, shrinking, or reshaping that part of the business. The current reading is $500K Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this common stock page, Stockcircle has CytRx's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $500K) with ownership activity and broader fundamentals.
CytRx's common stock is $500K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
